Rituximab provides steroid-sparing therapy in new-onset chronic graft-versus-host disease

0153

  • Arai, S.
  • Sahaf, B.
  • Otani, J.
  • Vashi, N.
  • Miklos, D.

  • University Medical Center (Stanford, US)

Bone Marrow Transplantation 46:p S7, April 2011.
Copyright © 2011 Nature Publishing Group
View full text|Download PDF